Compare Eli Lilly And Co (LLY) vs Marqeta Inc (MQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Marqeta Inc — how do they compare? Eli Lilly And Co trades at $1,170.93 (market cap $1.02T), while Marqeta Inc trades at $17.22 (market cap $1.85B). The key difference: Eli Lilly And Co is far larger — about 551.4× Marqeta Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| LLY | MQ | |
|---|---|---|
Market Cap | $1.02T | $1.85B |
Sector | Health | Technology |
52-Week High | $1.24K | $27.32 |
52-Week Low | $625.65 | $15.04 |
Enterprise Value | $1.06T | $1.15B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →
